a, Transcript levels of IFIT3 overlaid onto the UMAP embedding from Fig. 3a. b, Representative immunofluorescence images of C3 and IFIT3 staining (scale bar: 60 μm). c, Percent IFIT3−/C3+, IFIT3+/C3−, or IFIT3+/C3+ cells measured by immunofluorescence in iAstrocytes derived from multiple hiPSC lines (WTC11, TCW-1E44, 162D) treated with vehicle control vs. all possible combinations of IL-1α, TNF, and C1q, in the absence (n = 3 wells per condition) or presence of additional IL-6/IL6R chimera (25 ng/mL) or IFN-β (5 ng/mL) added concurrently (n = 4 wells per condition). D, Concentration of IFN-β, IL-6, CXCL10, or GM-CSF in conditioned media from iAstrocytes derived from multiple hiPSC lines (WTC11, 162D) treated with vehicle control vs. all possible combinations of IL-1α, TNF, and C1q (n = 4 wells). For panels c a, P values were calculated using beta regression (two-sided Wald test; see Methods). For panel d, P values were calculated using linear regression (two-sided Wald test; see Methods). P values were adjusted for multiple testing (Padj; Holm’s method) per family of tests (all comparisons within a plot).